To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MAZTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
468 supporting clones for gene MAZ back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CT001029 T-Lymphocytes .a 1 to 169 1 to 169   tiling clone,   169/169
(100 %)
2 diff
(98.9 %id)
NM_001042539.1   .a 158 to 2934 1 to 2777   RefSeq, AAA   2777/2777
(100 %)
0 diff
(100 %id)
AF489858   .a 220 to 2137 8 to 1919   tiling clone,   1912/1919
(99 %)
40 diff
(98.0 %id)
BE514418 Burkitt lymphoma, lymph .a 419 to 748 57 to 388       332/902
(36 %)
22 diff
(97.6 %id)
BQ225900 embryonal carcinoma, cell line, testis .a 957 to 1767 5 to 828       824/879
(93 %)
23 diff
(97.4 %id)
BG163806 hypernephroma, cell line, Kidney .a 958 to 1728 1 to 767       767/788
(97 %)
22 diff
(97.3 %id)
BX384497   .a 959 to 1824 850 to 1     Submitted on the opposite strand 850/954
(89 %)
20 diff
(98.0 %id)
BU839736 hepatocellular carcinoma, cell line, Liver .a 992 to 1695 19 to 730       712/1049
(67 %)
26 diff
(97.6 %id)
BQ649181 hepatocellular carcinoma, cell line, Liver .a 992 to 1702 3 to 718       716/928
(77 %)
15 diff
(98.4 %id)
BU147419 brain, neuroblastoma, cell line .a 1000 to 1749 1 to 753       753/831
(90 %)
13 diff
(98.5 %id)
BC041629 Primary B-Cells from Tonsils .a 1011 to 2917 1 to 1906   tiling clone, available from MGC, AAA   1906/1906
(100 %)
2 diff
(99.9 %id)
BE791153 lung, small cell carcinoma .a 1028 to 1765 1 to 745       745/926
(80 %)
24 diff
(97.5 %id)
BE791699 lung, small cell carcinoma .a 1028 to 1784 1 to 757       757/1001
(75 %)
12 diff
(98.9 %id)
BG744265 blood, natural killer cells, cell line .a 1076 to 1757 1 to 682       682/683
(99 %)
1 diff
(99.9 %id)
BQ052616 blood, natural killer cells, cell line .a 1079 to 1767 1 to 689       689/1110
(62 %)
5 diff
(99.6 %id)
BQ055692 lymph, lymphoma, cell line .a 1095 to 1767 1 to 672       672/1130
(59 %)
7 diff
(99.4 %id)
BQ056385 lymph, lymphoma, cell line .a 1095 to 1824 1 to 742       742/1139
(65 %)
18 diff
(98.5 %id)
BQ061660 lymph, lymphoma, cell line .a 1095 to 1827 1 to 747       747/1097
(68 %)
17 diff
(98.5 %id)
BQ066482 lymph, lymphoma, cell line .a 1095 to 1828 1 to 745       745/1032
(72 %)
17 diff
(98.4 %id)
BU150807 lymph, lymphoma, cell line .a 1095 to 1830 1 to 744       744/966
(77 %)
8 diff
(99.2 %id)
BI333287 cervical carcinoma cell line, cervix .a 1122 to 1755 1 to 634       634/634
(100 %)
0 diff
(100 %id)
CN258664 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1131 to 1756 1 to 626       626/626
(100 %)
1 diff
(99.9 %id)
BE799497 lung, small cell carcinoma .a 1135 to 1769 34 to 672       639/943
(67 %)
11 diff
(98.9 %id)
BM793095 Ascites, stomach .a 1151 to 1651 1 to 500       500/500
(100 %)
1 diff
(99.8 %id)
BE312260 brain, neuroblastoma .a 1174 to 1786 26 to 634       609/684
(89 %)
16 diff
(97.7 %id)
BM468044 melanotic melanoma, skin .a 1201 to 2016 27 to 843       817/993
(82 %)
29 diff
(97.1 %id)
BQ053591 blood, natural killer cells, cell line .a 1216 to 2016 1 to 803       803/1031
(77 %)
10 diff
(99.1 %id)
TI_59385475   .a 1222 to 1828 62 to 668       607/691
(87 %)
15 diff
(97.9 %id)
BM811103 amelanotic melanoma, cell line, skin .a 1223 to 1945 1 to 728       728/1106
(65 %)
10 diff
(99.1 %id)
BU521309 leiomyosarcoma, uterus .a 1227 to 1940 1 to 726       726/880
(82 %)
23 diff
(97.4 %id)
CD580359 brain .a 1230 to 1840 1 to 616       616/885
(69 %)
15 diff
(98.4 %id)
BQ056259 lymph, lymphoma, cell line .a 1232 to 1868 1 to 641       641/1080
(59 %)
14 diff
(98.8 %id)
BU956509 adenocarcinoma, cell line, breast .a 1298 to 1996 1 to 699       699/908
(76 %)
14 diff
(98.5 %id)
BU848978 ovary, teratocarcinoma, cell line .a 1356 to 2173 1 to 827       827/884
(93 %)
15 diff
(98.4 %id)
TI_57242254   .a 1362 to 2018 35 to 692       658/692
(95 %)
15 diff
(97.9 %id)
BQ053842 blood, natural killer cells, cell line .a 1389 to 2124 1 to 746       746/1118
(66 %)
29 diff
(97.5 %id)
BE253373 eye, retinoblastoma .a 1436 to 1869 1 to 434       434/437
(99 %)
2 diff
(99.6 %id)
TI_57193417   .a 1441 to 2117 54 to 726       673/674
(99 %)
17 diff
(97.5 %id)
BI861923 breast, mammary adenocarcinoma, cell line .a 1442 to 2117 1 to 672       672/673
(99 %)
17 diff
(97.5 %id)
CN258666 embryonic stem cells, cell lines H1, H7, andH9 .a 1454 to 1749 1 to 296       296/296
(100 %)
2 diff
(99.4 %id)
BQ064470 lymph, lymphoma, cell line .a 1492 to 2371 5 to 897       893/1012
(88 %)
56 diff
(94.5 %id)
CR998283 T-Lymphocytes .a 1493 to 1841 1 to 349       349/349
(100 %)
0 diff
(100 %id)
BI335031 cervical carcinoma cell line, cervix .a 1499 to 2364 1 to 862       862/886
(97 %)
40 diff
(95.5 %id)
BI333898 cervical carcinoma cell line, cervix .a 1499 to 2116 1 to 621       621/623
(99 %)
7 diff
(98.9 %id)
AK074720   .a 1535 to 2917 1 to 1384   available from FLJ,   1384/1384
(100 %)
3 diff
(99.8 %id)
DA728110   .a 1536 to 2053 2 to 518   capped   517/523
(98 %)
1 diff
(99.9 %id)
BM915781 amelanotic melanoma, cell line, skin .a 1541 to 2334 11 to 808       798/1021
(78 %)
12 diff
(98.9 %id)
BM423939 amelanotic melanoma, cell line, skin .a 1554 to 2206 1 to 660       660/1061
(62 %)
10 diff
(99.1 %id)
TI_154180499   .a 1558 to 2180 73 to 695       623/913
(68 %)
28 diff
(97.0 %id)
TI_59390781   .a 1580 to 2066 104 to 595       492/838
(58 %)
13 diff
(98.5 %id)
BC039057 Skin, normal .a 1594 to 2917 1 to 1324   available from MGC, AAA   1324/1324
(100 %)
1 diff
(100.0 %id)
BU596682 mixed (pool of 40 RNAs) .a 1640 to 2396 1 to 775       775/832
(93 %)
48 diff
(94.3 %id)
TI_57190348   .a 1645 to 2386 46 to 795       750/753
(99 %)
25 diff
(96.7 %id)
BU859749 adenocarcinoma, cell line, breast .a 1662 to 2442 1 to 794       794/857
(92 %)
9 diff
(99.0 %id)
BI333355 cervical carcinoma cell line, cervix .a 1671 to 2396 1 to 728       728/1055
(69 %)
14 diff
(98.7 %id)
BM853247 myeloma .a 1675 to 2022 1 to 348       348/348
(100 %)
0 diff
(100 %id)
BM741256 stomach .a 1704 to 1927 1 to 224       224/224
(100 %)
1 diff
(99.6 %id)
BM743034 stomach .a 1704 to 2355 1 to 652       652/652
(100 %)
2 diff
(99.7 %id)
BM753040 stomach .a 1704 to 2279 1 to 575       575/580
(99 %)
2 diff
(99.7 %id)
BM753776 stomach .a 1704 to 2133 1 to 433       433/433
(100 %)
5 diff
(98.9 %id)
BM753737 stomach .a 1704 to 2265 1 to 563       563/563
(100 %)
4 diff
(99.3 %id)
BM765711 stomach .a 1704 to 2017 1 to 315       315/315
(100 %)
2 diff
(99.4 %id)
BM765498 stomach .a 1704 to 2307 1 to 604       604/604
(100 %)
1 diff
(99.9 %id)
BM765748 stomach .a 1704 to 2247 1 to 544       544/544
(100 %)
1 diff
(99.9 %id)
BM766069 stomach .a 1704 to 2089 1 to 386       386/386
(100 %)
1 diff
(99.8 %id)
BM772874 stomach .a 1704 to 2127 1 to 424       424/424
(100 %)
0 diff
(100 %id)
BM772061 stomach .a 1704 to 2113 1 to 410       410/410
(100 %)
2 diff
(99.6 %id)
BM771650 stomach .a 1704 to 2327 1 to 624       624/624
(100 %)
2 diff
(99.7 %id)
BM772196 stomach .a 1704 to 2234 1 to 531       531/531
(100 %)
1 diff
(99.9 %id)
BM757552 Ascites, stomach .a 1704 to 2022 1 to 319       319/319
(100 %)
0 diff
(100 %id)
BX394754 Neuroblastoma Cot 25-normalized .a 1711 to 2290 1 to 578   fully sequenced,   578/578
(100 %)
7 diff
(98.8 %id)
BM728764 eye, fetal eye .a 1723 to 2387 1 to 669       669/669
(100 %)
5 diff
(99.3 %id)
BQ053562 blood, natural killer cells, cell line .a 1746 to 2447 1 to 704       704/1095
(64 %)
11 diff
(99.0 %id)
BF341182 brain, glioblastoma with EGFR amplification .a 1758 to 2448 1 to 692       692/890
(77 %)
13 diff
(98.6 %id)
AL523908.
matches multiple genes
brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1894 to 2895 993 to 1     also hits gene VGF 993/1086
(91 %)
32 diff
(97.1 %id)
CR601236 Neuroblastoma Cot 25-normalized .a 1900 to 2795 1 to 896       896/896
(100 %)
0 diff
(100 %id)
BX333692 Neuroblastoma Cot 25-normalized .a 1900 to 2914 1 to 1009       1009/1009
(100 %)
19 diff
(98.2 %id)
TI_154128293   .a 2025 to 2917 979 to 100   AAA   880/970
(90 %)
24 diff
(97.6 %id)
TI_149314421   .a 2037 to 2916 956 to 86   AAA   871/1004
(86 %)
16 diff
(98.5 %id)
BG034021 breast, mammary adenocarcinoma, cell line .a 2082 to 2865 1 to 779       779/830
(93 %)
45 diff
(94.6 %id)
CR590673 HeLa cells Cot 25-normalized .a 2087 to 2931 1 to 845   tiling clone,   845/845
(100 %)
0 diff
(100 %id)
BX363391   .a 2087 to 2931 1 to 846   fully sequenced,   846/846
(100 %)
3 diff
(99.7 %id)
TI_149289760   .a 2091 to 2930 958 to 126   AAA   833/940
(88 %)
29 diff
(97.0 %id)
TI_154124607   .a 2102 to 2917 884 to 75   AAA   810/977
(82 %)
11 diff
(98.9 %id)
TI_159690396   .a 2123 to 2934 893 to 88   AAA   806/1004
(80 %)
20 diff
(98.1 %id)
TI_159696663   .a 2127 to 2934 887 to 88   AAA   800/962
(83 %)
13 diff
(98.7 %id)
BG260604 bladder, transitional cell papilloma, cell line .a 2154 to 2906 1 to 748       748/923
(81 %)
27 diff
(97.1 %id)
BM689794 eye, Retina Foveal and Macular .a 2165 to 2450 9 to 295       287/295
(97 %)
2 diff
(99.4 %id)
CD390075 embryonic trophoblasts, made from WA01 stemcells .a 2171 to 2925 23 to 777   AAA   755/802
(94 %)
6 diff
(99.3 %id)
CB306066 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 2177 to 2916 758 to 19   AAA   740/741
(99 %)
0 diff
(100 %id)
CA430073 cell lines, Chondrosarcoma .a 2177 to 2917 760 to 19   AAA   742/743
(99 %)
3 diff
(99.6 %id)
BM718738 eye, fetal eye .a 2178 to 2789 1 to 612       612/612
(100 %)
0 diff
(100 %id)
BU535001 mixed (pool of 40 RNAs) .a 2187 to 2919 1 to 746       746/806
(92 %)
35 diff
(95.7 %id)
N56831 placenta .a 2188 to 2584 1 to 397   fully sequenced,   397/397
(100 %)
3 diff
(99.3 %id)
TI_149288850   .a 2189 to 2908 811 to 90   AAA   722/722
(100 %)
4 diff
(99.5 %id)
W17352 lung .a 2198 to 2561 1 to 364       364/374
(97 %)
3 diff
(99.2 %id)
BU539437 adenocarcinoma, cell line, breast .a 2202 to 2926 1 to 737       737/742
(99 %)
21 diff
(97.2 %id)
R27045 placenta .a 2208 to 2405 1 to 198       198/198
(100 %)
0 diff
(100 %id)
CX758387 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 2214 to 2917 722 to 26   AAA   697/784
(88 %)
28 diff
(96.5 %id)
TI_149288630   .a 2217 to 2917 796 to 94   AAA   703/703
(100 %)
2 diff
(99.8 %id)
TI_154050889   .a 2217 to 2917 782 to 91   AAA   692/957
(72 %)
23 diff
(97.6 %id)
AI471665 colon, moderately-differentiated adenocarcinoma .a 2224 to 2915 686 to 1       686/686
(100 %)
17 diff
(97.6 %id)
BX376041 Neuroblastoma Cot 25-normalized .a 2260 to 2872 650 to 36   fully sequenced,   615/650
(94 %)
15 diff
(97.7 %id)
BX363390   .a 2266 to 2895 631 to 1   fully sequenced,   631/631
(100 %)
2 diff
(99.7 %id)
CR623056 HeLa cells Cot 25-normalized .a 2285 to 2878 1 to 594       594/594
(100 %)
0 diff
(100 %id)
BM970459 lung .a 2290 to 2917 648 to 19   AAA   630/630
(100 %)
2 diff
(99.7 %id)
BU681433 lung .a 2290 to 2908 635 to 15   AAA   621/621
(100 %)
2 diff
(99.7 %id)
BU627797 Bone, Enchondroma cell line .a 2290 to 2917 646 to 19   AAA   628/628
(100 %)
0 diff
(100 %id)
CA429200 Cell Line, Chondrosarcoma .a 2290 to 2908 634 to 15   AAA   620/620
(100 %)
2 diff
(99.7 %id)
BM996090 lung, Metastatic Chondrosarcoma .a 2326 to 2917 611 to 19   AAA   593/593
(100 %)
3 diff
(99.5 %id)
TI_154135487   .a 2344 to 2917 671 to 95   AAA   577/578
(99 %)
19 diff
(96.8 %id)
BU615653 cell lines, Chondrosarcoma .a 2367 to 2930 583 to 19   AAA   565/565
(100 %)
1 diff
(99.9 %id)
BU634059 cell lines, Chondrosarcoma .a 2367 to 2908 557 to 15   AAA   543/543
(100 %)
3 diff
(99.5 %id)
BF434107 fibrotheoma, ovary .a 2379 to 2917 542 to 4       539/542
(99 %)
0 diff
(100 %id)
AI590587 ovary, tumor, 5 pooled (see description) .a 2385 to 2917 535 to 3       533/535
(99 %)
0 diff
(100 %id)
CA426222 Bone, Subchondral Bone .a 2390 to 2917 546 to 19   AAA   528/528
(100 %)
0 diff
(100 %id)
BU628140 Bone, Enchondroma cell line .a 2390 to 2917 545 to 19   AAA   527/527
(100 %)
3 diff
(99.5 %id)
CA414153 Knee, Osteoarthritic Cartilage .a 2396 to 2917 541 to 19   AAA   523/523
(100 %)
1 diff
(99.9 %id)
AW081487 colon, moderately differentiated adenocarcinoma .a 2406 to 2917 532 to 23   AAA   510/510
(100 %)
5 diff
(99.1 %id)
BF529943 anaplastic oligodendroglioma with 1p/19qloss, brain .a 2409 to 2910 26 to 534       509/652
(78 %)
58 diff
(91.2 %id)
TI_154176678   .a 2417 to 2904 101 to 589       489/1037
(47 %)
15 diff
(98.6 %id)
CK819279 Islets of Langerhans, Pancreas .a 2425 to 2917 511 to 19   AAA   493/493
(100 %)
1 diff
(99.8 %id)
AI498012 anaplastic oligodendroglioma, brain .a 2430 to 2908 490 to 12   AAA   479/479
(100 %)
0 diff
(100 %id)
AI692261 adenocarcinoma, Pancreas .a 2430 to 2909 480 to 1       480/480
(100 %)
0 diff
(100 %id)
AI480172 anaplastic oligodendroglioma, brain .a 2435 to 2917 499 to 17   AAA   483/483
(100 %)
3 diff
(99.4 %id)
AI970591 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 2435 to 2908 485 to 14   AAA   472/472
(100 %)
2 diff
(99.6 %id)
BU742682 eye, fetal eye .a 2442 to 2917 493 to 19   AAA   475/475
(100 %)
1 diff
(99.8 %id)
AA927401 pooled .a 2446 to 2790 1 to 345     Submitted on the opposite strand 345/345
(100 %)
3 diff
(99.2 %id)
BQ940596 leiomyosarcoma, uterus .a 2448 to 2917 1 to 470   AAA   470/470
(100 %)
0 diff
(100 %id)
BF791405 adrenal cortex carcinoma, cell line, adrenal gland .a 2455 to 2917 1 to 463   AAA   463/463
(100 %)
2 diff
(99.6 %id)
BF339415 brain, glioblastoma with EGFR amplification .a 2462 to 2917 1 to 456   AAA   456/456
(100 %)
0 diff
(100 %id)
CN258663 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2464 to 2912 1 to 450       450/451
(99 %)
4 diff
(99.2 %id)
AI225094 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2467 to 2916 451 to 2       450/451
(99 %)
0 diff
(100 %id)
BM467842 leiomyosarcoma, uterus .a 2473 to 2917 1 to 445   AAA   445/445
(100 %)
1 diff
(99.8 %id)
BM661834 eye, Retina Foveal and Macular .a 2474 to 2917 462 to 19   AAA   444/444
(100 %)
3 diff
(99.4 %id)
BM695402 eye, optic nerve .a 2479 to 2934 1 to 456   tiling clone, AAA   456/456
(100 %)
0 diff
(100 %id)
BM793035 Ascites, stomach .a 2481 to 2917 1 to 437   AAA   437/437
(100 %)
0 diff
(100 %id)
BM797712 Ascites, stomach .a 2492 to 2916 1 to 425       425/425
(100 %)
0 diff
(100 %id)
TI_149292748   .a 2492 to 2917 491 to 67   AAA   425/703
(60 %)
9 diff
(98.8 %id)
BM703601 eye, human retina .a 2492 to 2908 1 to 417   AAA   417/417
(100 %)
0 diff
(100 %id)
AA551119 Schwannoma tumor .a 2500 to 2917 418 to 2       417/418
(99 %)
0 diff
(100 %id)
BU556601 ovary, teratocarcinoma, cell line .a 2505 to 2917 1 to 413   AAA   413/413
(100 %)
0 diff
(100 %id)
AA132842 colon, tumor .a 2508 to 2809 1 to 305   fully sequenced,   305/305
(100 %)
5 diff
(98.4 %id)
BM128303 Islets of Langerhans, Pancreas .a 2511 to 2917 425 to 19   AAA   407/407
(100 %)
4 diff
(99.1 %id)
T58104 fetal spleen, Spleen .a 2516 to 2706 1 to 197   fully sequenced,   197/197
(100 %)
2 diff
(99.0 %id)
BM788962 stomach .a 2523 to 2909 1 to 387   AAA   387/387
(100 %)
1 diff
(99.8 %id)
AI360548 adenocarcinoma, Pancreas .a 2528 to 2934 416 to 11   AAA   406/406
(100 %)
1 diff
(99.8 %id)
F36901 pectoral muscle (after mastectomy) .a 2553 to 2920 1 to 368       368/368
(100 %)
0 diff
(100 %id)
N32411 placenta .a 2554 to 2909 357 to 1   fully sequenced,   357/357
(100 %)
5 diff
(98.6 %id)
F33272 pectoral muscle (after mastectomy) .a 2561 to 2925 1 to 365   AAA   365/365
(100 %)
3 diff
(99.2 %id)
BU730630 eye, RPE and Choroid .a 2569 to 2917 367 to 19   AAA   349/349
(100 %)
2 diff
(99.5 %id)
BQ216135 embryonal carcinoma, cell line, testis .a 2580 to 2917 1 to 338   AAA   338/338
(100 %)
0 diff
(100 %id)
BQ773537 Chondrosarcoma Cell line .a 2591 to 2917 345 to 19   AAA   327/327
(100 %)
0 diff
(100 %id)
D55460   .a 2597 to 2909 1 to 312       312/312
(100 %)
2 diff
(99.4 %id)
AJ573262 pectoral muscle (after mastectomy) .a 2610 to 2907 1 to 298       298/298
(100 %)
0 diff
(100 %id)
BM929592 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2620 to 2917 1 to 298   AAA   298/298
(100 %)
0 diff
(100 %id)
BE543776 cervical carcinoma cell line, cervix .a 2627 to 2917 1 to 290   AAA   290/290
(100 %)
1 diff
(99.7 %id)
BM712401 eye, lens .a 2628 to 2908 1 to 281   fully sequenced, AAA   281/281
(100 %)
0 diff
(100 %id)
BG393597 embryonal carcinoma, cell line, testis .a 2633 to 2917 1 to 284   AAA   284/284
(100 %)
1 diff
(99.7 %id)
F15962 pectoral muscle (after mastectomy) .a 2652 to 2931 1 to 280       280/280
(100 %)
2 diff
(99.3 %id)
AA742565 pooled germ cell tumors .a 2666 to 2917 285 to 35   AAA   251/251
(100 %)
2 diff
(99.3 %id)
FN060146 breast carcinoma .a 2672 to 2787 1 to 115       115/115
(100 %)
2 diff
(98.3 %id)
T58038 fetal spleen, Spleen .a 2676 to 2899 229 to 1   fully sequenced,   229/229
(100 %)
2 diff
(99.2 %id)
N78961 lung .a 2683 to 2917 235 to 2       234/235
(99 %)
0 diff
(100 %id)
CD106068 brain, Pituitary .a 2693 to 2917 1 to 225   AAA   225/225
(100 %)
0 diff
(100 %id)
AA300258 uterus .a 2700 to 2916 217 to 1       217/217
(100 %)
0 diff
(100 %id)
D53213   .a 2704 to 2917 1 to 214       214/214
(100 %)
0 diff
(100 %id)
D55479   .a 2704 to 2917 1 to 214       214/214
(100 %)
0 diff
(100 %id)
AV648031 corresponding non cancerous liver tissue .a 2709 to 2916 1 to 208   AAA Submitted on the opposite strand 208/208
(100 %)
0 diff
(100 %id)
R27046 placenta .a 2710 to 2908 198 to 1       198/198
(100 %)
1 diff
(99.5 %id)
AA292926 ovarian tumor, ovary .a 2720 to 2917 198 to 1       198/198
(100 %)
0 diff
(100 %id)
AW090821 brain, tumor, 5 pooled (see description) .a 2736 to 2917 182 to 1       182/182
(100 %)
1 diff
(99.5 %id)
AW015316   .a 2746 to 2925 197 to 18   AAA   180/180
(100 %)
0 diff
(100 %id)
FN087357 breast carcinoma .a 2761 to 2846 1 to 84       84/85
(98 %)
3 diff
(96.5 %id)
CA308384 Alveolar Macrophage, lung .a 2767 to 2917 169 to 19   AAA   151/151
(100 %)
0 diff
(100 %id)
FN062359 breast carcinoma .a 2775 to 2889 1 to 117       117/117
(100 %)
3 diff
(97.5 %id)
AA132713 colon, tumor .a 2779 to 2915 140 to 1   fully sequenced,   140/140
(100 %)
1 diff
(99.3 %id)
FN169284 breast carcinoma .a 2783 to 2857 1 to 72       72/74
(97 %)
3 diff
(96.0 %id)
CA946297 eye, lacrimal gland .a 2814 to 2880 1 to 67       67/67
(100 %)
0 diff
(100 %id)
BI260874 cervical carcinoma cell line, cervix .a 2825 to 2917 1 to 93       93/109
(85 %)
1 diff
(99.1 %id)
BU738300 eye, lens .a 2833 to 2917 94 to 10   fully sequenced,   85/94
(90 %)
6 diff
(93.7 %id)
FN085403 breast carcinoma .a 2844 to 2923 1 to 82       82/83
(98 %)
3 diff
(96.4 %id)
GD138296   .a 2849 to 2917 1 to 69       69/84
(82 %)
4 diff
(95.3 %id)
GD151847   .a 2849 to 2917 1 to 69       69/83
(83 %)
6 diff
(92.8 %id)
GD159769   .a 2849 to 2912 1 to 63       63/77
(81 %)
4 diff
(94.9 %id)
GD161327   .a 2849 to 2926 1 to 77   AAA   77/77
(100 %)
3 diff
(96.2 %id)
NM_002383.2   .b 1 to 2552 1 to 2552 exact RefSeq, AAA   2552/2552
(100 %)
0 diff
(100 %id)
U33819   .b 47 to 1755 58 to 1767   tiling clone,   1710/1767
(96 %)
10 diff
(99.5 %id)
M93339   .b 118 to 1755 1 to 1638   tiling clone,   1638/1638
(100 %)
2 diff
(99.9 %id)
M94046   .b 147 to 2535 1 to 2389       2389/2389
(100 %)
13 diff
(99.5 %id)
EF059746   .b 169 to 1602 1 to 1434       1434/1434
(100 %)
0 diff
(100 %id)
BM720601 eye, fetal eye .b 919 to 1577 1 to 660       660/660
(100 %)
1 diff
(99.9 %id)
CR620008 HeLa cells Cot 25-normalized .b 992 to 2498 1 to 1507   tiling clone,   1507/1507
(100 %)
0 diff
(100 %id)
BX383783   .b 1008 to 1643 18 to 652   fully sequenced,   635/652
(97 %)
6 diff
(99.1 %id)
BX456269 thymus .b 1208 to 1923 10 to 719   fully sequenced,   710/710
(100 %)
2 diff
(99.8 %id)
AA129873 uterus .b 1303 to 1494 1 to 192       192/192
(100 %)
4 diff
(98.0 %id)
BX383782   .b 1613 to 2498 887 to 1   fully sequenced,   887/887
(100 %)
7 diff
(99.3 %id)
BX436275 thymus .b 1893 to 2535 634 to 1   tiling clone, fully sequenced,   634/634
(100 %)
15 diff
(97.7 %id)
BM679314 eye, fetal eye .b 2061 to 2535 493 to 19   AAA   475/475
(100 %)
0 diff
(100 %id)
AA129874 uterus .b 2367 to 2535 174 to 6       169/174
(97 %)
0 diff
(100 %id)
FJ532357   .c 1 to 2333 1 to 2333 exact tiling clone,   2333/2333
(100 %)
2 diff
(100.0 %id)
BM552314 leiomyosarcoma, uterus .c 71 to 266 1 to 196       196/196
(100 %)
0 diff
(100 %id)
BI909543 leukocyte .c 100 to 267 1 to 168       168/168
(100 %)
1 diff
(99.5 %id)
BM129635 Islets of Langerhans, Pancreas .c 122 to 267 1 to 146   fully sequenced,   146/146
(100 %)
0 diff
(100 %id)
BM129350 Islets of Langerhans, Pancreas .c 152 to 266 115 to 1   fully sequenced,   115/115
(100 %)
0 diff
(100 %id)
AW572635 lymph node, lymphoma, follicular mixed small and largecell .c 267 to 651 1 to 385     Submitted on the opposite strand 385/385
(100 %)
2 diff
(99.5 %id)
AI018189 pooled .c 268 to 702 1 to 435     Submitted on the opposite strand 435/435
(100 %)
0 diff
(100 %id)
AI827731 pooled .c 268 to 718 1 to 451     Submitted on the opposite strand 451/453
(99 %)
4 diff
(99.2 %id)
AI831058 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c 268 to 732 1 to 464     Submitted on the opposite strand 464/464
(100 %)
1 diff
(99.8 %id)
AI990450 thymus, pooled .c 268 to 728 1 to 461     Submitted on the opposite strand 461/461
(100 %)
1 diff
(99.8 %id)
AW592700 pooled .c 268 to 732 1 to 464     Submitted on the opposite strand 464/469
(98 %)
2 diff
(99.6 %id)
BF732504 fibrotheoma, ovary .c 268 to 722 1 to 455     Submitted on the opposite strand 455/455
(100 %)
1 diff
(99.8 %id)
AW204295   .c 269 to 631 1 to 363     Submitted on the opposite strand 363/363
(100 %)
1 diff
(99.8 %id)
AW292088   .c 269 to 712 1 to 444     Submitted on the opposite strand 444/444
(100 %)
0 diff
(100 %id)
BF516485   .c 269 to 706 1 to 438     Submitted on the opposite strand 438/438
(100 %)
0 diff
(100 %id)
AI738419 colon, colon tumor, RER+ .c 277 to 766 1 to 490     Submitted on the opposite strand 490/490
(100 %)
0 diff
(100 %id)
AI141095 lung .c 286 to 735 1 to 449     Submitted on the opposite strand 449/449
(100 %)
1 diff
(99.8 %id)
AI391563 B-cell, chronic lymphotic leukemia .c 296 to 445 1 to 150     Submitted on the opposite strand 150/150
(100 %)
0 diff
(100 %id)
BF000610 colon, colon tumor, RER+ .c 307 to 722 1 to 416     Submitted on the opposite strand 416/416
(100 %)
3 diff
(99.3 %id)
AW592036 pooled .c 327 to 708 1 to 381     Submitted on the opposite strand 381/384
(99 %)
3 diff
(99.3 %id)
DA084098 cerebellum .c 391 to 842 2 to 454   capped   453/453
(100 %)
1 diff
(99.8 %id)
BX331616 Neuroblastoma Cot 10-normalized .c 424 to 1302 1 to 877       877/877
(100 %)
7 diff
(99.3 %id)
DA889559   .c 434 to 989 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BQ434824 melanotic melanoma, skin .c 437 to 1200 1 to 769       769/832
(92 %)
8 diff
(99.1 %id)
DA619891   .c 437 to 962 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
BG342222 B-cells, primary B-cells from tonsils (cell line) .c 444 to 1076 29 to 666       638/1017
(62 %)
14 diff
(98.7 %id)
BF976189 B-cells, primary B-cells from tonsils (cell line) .c 464 to 1195 1 to 729       731/934
(78 %)
23 diff
(97.6 %id)
CX786409 human embryonic stem cells .c 467 to 1155 1 to 689       689/689
(100 %)
1 diff
(99.9 %id)
BI116654 lung, small cell carcinoma .c 480 to 1162 1 to 693       693/906
(76 %)
22 diff
(97.6 %id)
L01420   .c 559 to 1552 1 to 993       993/993
(100 %)
8 diff
(99.2 %id)
CN258668 embryonic stem cells, cell lines H1, H7, andH9 .c 611 to 899 1 to 289       289/289
(100 %)
2 diff
(99.4 %id)
BX400285   .c 621 to 1374 1 to 741       741/846
(87 %)
19 diff
(97.8 %id)
EC467065 Prostate .c 631 to 738 108 to 1       108/108
(100 %)
0 diff
(100 %id)
BG253675 adenocarcinoma, cell line, Prostate .c 652 to 1415 1 to 763       763/921
(82 %)
21 diff
(97.8 %id)
BM561577 blood, natural killer cells, cell line .c 661 to 1382 1 to 730       730/1029
(70 %)
16 diff
(98.5 %id)
BG774115 choriocarcinoma, placenta .c 665 to 1433 1 to 770       770/925
(83 %)
7 diff
(99.3 %id)
BE299873 muscle, rhabdomyosarcoma .c 679 to 1426 1 to 766       766/771
(99 %)
20 diff
(97.5 %id)
BQ231553 embryonal carcinoma, cell line, testis .c 685 to 1441 800 to 31     Submitted on the opposite strand 770/917
(83 %)
22 diff
(97.7 %id)
BG819112 anaplastic oligodendroglioma with 1p/19qloss, brain .c 704 to 1395 1 to 696       696/699
(99 %)
6 diff
(99.2 %id)
BU932064 ovary, teratocarcinoma, cell line .c 715 to 1584 1 to 893       893/950
(94 %)
12 diff
(98.8 %id)
BI116735 lung, small cell carcinoma .c 721 to 1446 1 to 745       745/745
(100 %)
36 diff
(95.2 %id)
EC545396 Prostate .c 736 to 838 1 to 103       103/103
(100 %)
0 diff
(100 %id)
BM918210 blood, natural killer cells, cell line .c 742 to 1626 1 to 895       895/1041
(85 %)
21 diff
(98.0 %id)
EC471957 Prostate .c 743 to 838 14 to 109       96/109
(88 %)
6 diff
(94.5 %id)
EC459017 Prostate .c 748 to 852 109 to 7       103/109
(94 %)
5 diff
(95.5 %id)
EC500478 Prostate .c 748 to 851 105 to 2       104/105
(99 %)
0 diff
(100 %id)
W79269 heart .c 754 to 990 234 to 1     Submitted on the opposite strand 234/280
(83 %)
8 diff
(97.2 %id)
AA280784 germinal center B cell .c 755 to 989 245 to 3     Submitted on the opposite strand 243/282
(86 %)
0 diff
(100 %id)
BI092498 cervix .c 788 to 1485 1 to 698       698/698
(100 %)
3 diff
(99.6 %id)
BQ695173 adipose .c 798 to 1372 1 to 577       577/645
(89 %)
11 diff
(98.3 %id)
ES307601 beard hair, skin .c 798 to 962 1 to 164       164/164
(100 %)
3 diff
(98.2 %id)
BQ694236 adipose .c 800 to 1426 1 to 625       625/628
(99 %)
6 diff
(99.1 %id)
CN258671 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 829 to 1378 1 to 550       550/550
(100 %)
1 diff
(99.9 %id)
BI195620 brain, neuroblastoma .c 843 to 1273 1 to 431       431/431
(100 %)
2 diff
(99.6 %id)
BI196663 brain, neuroblastoma .c 843 to 1438 1 to 596       596/596
(100 %)
10 diff
(98.4 %id)
BM555007 amelanotic melanoma, cell line, skin .c 849 to 1426 27 to 604       578/1176
(49 %)
15 diff
(98.8 %id)
BM912468 amelanotic melanoma, cell line, skin .c 849 to 1403 8 to 561       554/1136
(48 %)
17 diff
(98.6 %id)
BM809685 amelanotic melanoma, cell line, skin .c 853 to 1436 1 to 590       590/1190
(49 %)
8 diff
(99.4 %id)
BM911941 amelanotic melanoma, cell line, skin .c 853 to 1438 1 to 584       584/595
(98 %)
16 diff
(97.4 %id)
CX754066 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 856 to 1426 1 to 571     Submitted on the opposite strand 571/712
(80 %)
8 diff
(98.9 %id)
BE259776 brain, neuroblastoma .c 861 to 1528 1 to 665       665/668
(99 %)
5 diff
(99.3 %id)
BQ053868 blood, natural killer cells, cell line .c 861 to 1736 1 to 892       892/1021
(87 %)
29 diff
(97.2 %id)
BG424103 Kidney, renal cell adenocarcinoma .c 862 to 1525 1 to 657       657/861
(76 %)
10 diff
(98.9 %id)
CN258658 embryonic stem cells, DMSO-treated H9 cellline .c 869 to 1595 3 to 731       729/732
(99 %)
9 diff
(98.8 %id)
BU502415 mixed (pool of 40 RNAs) .c 879 to 1557 1 to 694       694/886
(78 %)
37 diff
(95.9 %id)
BF811600 colon_ins .c 887 to 1113 1 to 230       230/230
(100 %)
23 diff
(90.0 %id)
EC554309 Prostate .c 891 to 977 87 to 1       87/87
(100 %)
5 diff
(94.3 %id)
AA262039 germinal center B cell .c 891 to 992 101 to 1     Submitted on the opposite strand 101/101
(100 %)
5 diff
(95.1 %id)
CN258665 embryonic stem cells, cell lines H1, H7, andH9 .c 895 to 1625 1 to 731       731/731
(100 %)
3 diff
(99.6 %id)
BG420213 Kidney, renal cell adenocarcinoma .c 895 to 1542 1 to 648       648/898
(72 %)
18 diff
(98.0 %id)
EC475707 Prostate .c 897 to 975 80 to 1       80/83
(96 %)
6 diff
(92.8 %id)
BM854389 stomach .c 900 to 1408 1 to 509       509/509
(100 %)
1 diff
(99.9 %id)
BM857256 stomach .c 900 to 1373 1 to 474       474/474
(100 %)
2 diff
(99.6 %id)
BM829798 stomach .c 900 to 1425 1 to 526       526/526
(100 %)
0 diff
(100 %id)
BF811594 colon_ins .c 902 to 1109 1 to 214       214/219
(97 %)
11 diff
(95.0 %id)
BY796587 eye .c 905 to 1442 1 to 538       538/538
(100 %)
0 diff
(100 %id)
BM546287 ovary (pool of 3) .c 908 to 1533 12 to 638       627/1145
(54 %)
19 diff
(98.4 %id)
BQ226386 melanotic melanoma, skin .c 921 to 1754 1 to 837       837/868
(96 %)
9 diff
(99.0 %id)
TI_59388190   .c 926 to 1433 110 to 617       508/806
(63 %)
1 diff
(99.9 %id)
BM020572 astrocytoma grade IV, cell line, brain .c 928 to 1433 1 to 506       506/804
(62 %)
1 diff
(99.9 %id)
BM563022 astrocytoma grade IV, cell line, brain .c 929 to 1742 1 to 822       822/1041
(78 %)
23 diff
(97.8 %id)
BE796686 lung, small cell carcinoma .c 938 to 1561 1 to 629       629/632
(99 %)
6 diff
(99.1 %id)
BE744223 adenocarcinoma cell line, ovary .c 952 to 1739 1 to 782       782/785
(99 %)
13 diff
(98.4 %id)
BU146040 epidermoid carcinoma, cell line, salivary gland .c 963 to 1510 1 to 563       563/1054
(53 %)
29 diff
(97.3 %id)
TI_154188433   .c 977 to 1821 121 to 960       840/922
(91 %)
21 diff
(97.8 %id)
BE622019 melanotic melanoma, skin .c 981 to 1746 1 to 765       765/799
(95 %)
43 diff
(94.7 %id)
EC549387 Prostate .c 1006 to 1085 1 to 81       81/93
(87 %)
8 diff
(91.4 %id)
EC482052 Prostate .c 1019 to 1111 1 to 93       93/93
(100 %)
0 diff
(100 %id)
CA487565   .c 1024 to 1998 1 to 989       989/1021
(96 %)
35 diff
(96.6 %id)
CX870361 embryonic stem .c 1032 to 1675 1 to 644       644/644
(100 %)
1 diff
(99.9 %id)
BM794504 Ascites, stomach .c 1045 to 1462 1 to 418       418/418
(100 %)
5 diff
(98.9 %id)
BM796126 Ascites, stomach .c 1045 to 1425 1 to 381       381/381
(100 %)
1 diff
(99.8 %id)
BF972352 leiomyosarcoma cell line, uterus .c 1048 to 1829 1 to 793       793/1140
(69 %)
48 diff
(95.8 %id)
BG339395 leiomyosarcoma cell line, uterus .c 1048 to 1844 1 to 789       789/946
(83 %)
30 diff
(96.9 %id)
W27745 eye, retina .c 1049 to 1566 7 to 532       526/534
(98 %)
28 diff
(94.8 %id)
CF140902 CNCAP(3)T-225 cell line, Prostate .c 1053 to 1347 1 to 295       295/295
(100 %)
5 diff
(98.4 %id)
BQ671103 epidermoid carcinoma, cell line, salivary gland .c 1075 to 1858 1 to 787       787/908
(86 %)
10 diff
(98.9 %id)
BU526484 epidermoid carcinoma, cell line, lung .c 1076 to 1886 1 to 818       818/968
(84 %)
21 diff
(97.9 %id)
EC510602 Prostate .c 1095 to 1184 1 to 90       90/90
(100 %)
0 diff
(100 %id)
AI905847 breast .c 1102 to 1278 196 to 20       177/196
(90 %)
2 diff
(99.0 %id)
CF130948 Chondrosarcoma Lung Metastasis cell lines, lung .c 1138 to 1305 1 to 168       168/168
(100 %)
0 diff
(100 %id)
BE259566 brain, neuroblastoma .c 1157 to 1505 1 to 376       342/380
(90 %)
35 diff
(90.8 %id)
BE791834 lung, small cell carcinoma .c 1207 to 1900 1 to 692       692/955
(72 %)
16 diff
(98.4 %id)
BE018921 Kidney, renal cell adenocarcinoma .c 1209 to 1703 9 to 501       493/501
(98 %)
2 diff
(99.7 %id)
CR603028 fetal liver .c 1214 to 2278 1 to 1065   tiling clone,   1065/1065
(100 %)
0 diff
(100 %id)
BX427939 fetal liver, Liver .c 1214 to 1733 1 to 524   fully sequenced,   524/524
(100 %)
6 diff
(98.9 %id)
BE791806 lung, small cell carcinoma .c 1218 to 2016 1 to 800       800/992
(80 %)
31 diff
(96.9 %id)
BE796490 lung, small cell carcinoma .c 1219 to 2025 1 to 801       801/964
(83 %)
26 diff
(97.4 %id)
BE880479 large cell carcinoma, undifferentiated, lung .c 1220 to 2001 1 to 782       782/819
(95 %)
48 diff
(94.2 %id)
CA975935 sciatic nerve .c 1247 to 2010 15 to 797       783/964
(81 %)
45 diff
(95.4 %id)
BU957138 adenocarcinoma, cell line, breast .c 1248 to 1965 8 to 731       724/897
(80 %)
21 diff
(97.7 %id)
BP264918 muscle .c 1258 to 1936 1 to 683       683/683
(100 %)
14 diff
(98.0 %id)
CN258673 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 1263 to 1872 1 to 611       611/611
(100 %)
4 diff
(99.4 %id)
BG287676 bladder, transitional cell papilloma, cell line .c 1272 to 1921 1 to 654       654/654
(100 %)
11 diff
(98.4 %id)
BM753157 stomach .c 1290 to 1399 1 to 111       111/111
(100 %)
1 diff
(99.1 %id)
BE783285 eye, retinoblastoma .c 1292 to 1997 1 to 703       703/786
(89 %)
25 diff
(96.9 %id)
AW610413 stomach .c 1309 to 1822 1 to 513       513/517
(99 %)
9 diff
(98.3 %id)
AW610464 stomach .c 1309 to 1822 1 to 513       513/517
(99 %)
9 diff
(98.3 %id)
TI_57189354   .c 1328 to 2022 35 to 735       701/739
(94 %)
5 diff
(99.4 %id)
CN258657 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1329 to 1880 13 to 564       552/564
(97 %)
6 diff
(99.0 %id)
BI861425 breast, mammary adenocarcinoma, cell line .c 1338 to 2022 1 to 690       690/694
(99 %)
10 diff
(98.6 %id)
EC451451 Prostate .c 1349 to 1464 1 to 115       115/115
(100 %)
3 diff
(97.4 %id)
EC582061 Prostate .c 1349 to 1464 1 to 115       115/115
(100 %)
3 diff
(97.4 %id)
BG254835 adenocarcinoma, cell line, Prostate .c 1364 to 1979 1 to 625       625/692
(90 %)
28 diff
(96.0 %id)
BG255141 adenocarcinoma, cell line, Prostate .c 1364 to 1840 1 to 486       486/1080
(45 %)
20 diff
(98.2 %id)
CN258675 embryonic stem cells, DMSO-treated H9 cellline .c 1374 to 1815 1 to 442       442/442
(100 %)
3 diff
(99.4 %id)
AW249175 lung, small cell carcinoma .c 1376 to 1880 10 to 514       505/514
(98 %)
4 diff
(99.3 %id)
BE264373 lung, small cell carcinoma .c 1376 to 2025 1 to 652       652/655
(99 %)
12 diff
(98.2 %id)
BQ675350 epidermoid carcinoma, cell line, salivary gland .c 1395 to 1899 1 to 505       505/981
(51 %)
10 diff
(99.0 %id)
CN258659 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1424 to 1926 1 to 502       502/502
(100 %)
2 diff
(99.7 %id)
AA284020 germinal center B cell .c 1429 to 1717 1 to 288       288/288
(100 %)
5 diff
(98.3 %id)
TI_154142852   .c 1429 to 1966 78 to 613       536/813
(65 %)
29 diff
(96.5 %id)
AI125135 brain, pooled frontal lobe .c 1430 to 1664 181 to 415     Submitted on the opposite strand 235/415
(56 %)
6 diff
(98.6 %id)
CN483327 eye .c 1457 to 1991 1 to 534       534/534
(100 %)
5 diff
(99.1 %id)
N86506   .c 1463 to 1575 1 to 111       111/111
(100 %)
2 diff
(98.2 %id)
BM831833 stomach .c 1492 to 1836 1 to 345       345/345
(100 %)
1 diff
(99.8 %id)
CK819280 Islets of Langerhans, Pancreas .c 1514 to 2069 1 to 556       556/556
(100 %)
1 diff
(99.9 %id)
CN258672 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1520 to 1946 1 to 426       426/426
(100 %)
3 diff
(99.3 %id)
BF033941 adenocarcinoma, ovary .c 1525 to 2312 1 to 782       782/838
(93 %)
63 diff
(92.5 %id)
BM128507 Islets of Langerhans, Pancreas .c 1530 to 2007 1 to 479       479/479
(100 %)
2 diff
(99.6 %id)
BG030065 breast, mammary adenocarcinoma, cell line .c 1552 to 2309 1 to 755       755/898
(84 %)
55 diff
(93.9 %id)
CB052874 leiomyosarcoma, soft tissue .c 1554 to 1996 24 to 467       444/467
(95 %)
6 diff
(98.8 %id)
BG821540 adenocarcinoma cell line, colon .c 1558 to 2159 1 to 604       604/604
(100 %)
9 diff
(98.6 %id)
CB117225 Liver .c 1559 to 1818 1 to 260       260/260
(100 %)
2 diff
(99.3 %id)
BM821664 stomach .c 1559 to 2091 1 to 531       531/531
(100 %)
3 diff
(99.5 %id)
BM839768 stomach .c 1559 to 1926 1 to 369       369/369
(100 %)
2 diff
(99.5 %id)
BE274206 melanotic melanoma, skin .c 1580 to 1900 1 to 320       320/320
(100 %)
3 diff
(99.1 %id)
BU539747 adenocarcinoma, cell line, breast .c 1592 to 2224 1 to 633       633/928
(68 %)
27 diff
(97.1 %id)
BM762147 myeloma .c 1595 to 2117 1 to 524       524/524
(100 %)
4 diff
(99.3 %id)
BM761956 myeloma .c 1595 to 1972 1 to 377       377/377
(100 %)
2 diff
(99.5 %id)
AA380590   .c 1666 to 1916 1 to 248       248/248
(100 %)
3 diff
(98.8 %id)
BF529224 anaplastic oligodendroglioma with 1p/19qloss, brain .c 1666 to 2176 1 to 528       528/1001
(52 %)
14 diff
(98.7 %id)
AA300257 uterus .c 1676 to 1888 1 to 212       212/212
(100 %)
1 diff
(99.6 %id)
W16984 lung .c 1681 to 1962 1 to 283       283/283
(100 %)
1 diff
(99.7 %id)
BX427938 fetal liver, Liver .c 1708 to 2278 567 to 1   fully sequenced,   567/567
(100 %)
6 diff
(99.0 %id)
AI703218 pooled .c 1838 to 2153 1 to 316     Submitted on the opposite strand 316/316
(100 %)
2 diff
(99.4 %id)
AI187905   .c 1846 to 2127 1 to 282     Submitted on the opposite strand 282/282
(100 %)
0 diff
(100 %id)
FN119395 breast carcinoma .c 1850 to 1928 1 to 77       77/77
(100 %)
2 diff
(97.5 %id)
FN125388 breast carcinoma .c 1856 to 1922 1 to 67       67/68
(98 %)
1 diff
(98.6 %id)
AW577850 colon_normal .c 1875 to 2008 3 to 135       133/145
(91 %)
7 diff
(95.2 %id)
AA316481 colon .c 1897 to 2114 1 to 218       218/218
(100 %)
1 diff
(99.6 %id)
FN128063 breast carcinoma .c 1981 to 2055 1 to 74       74/75
(98 %)
2 diff
(97.4 %id)
FN082700 breast carcinoma .c 1990 to 2049 1 to 60       60/69
(86 %)
2 diff
(97.2 %id)
FN143226 breast carcinoma .c 1991 to 2051 1 to 58       58/58
(100 %)
3 diff
(94.9 %id)
FN107135 breast carcinoma .c 2096 to 2154 1 to 59       59/60
(98 %)
1 diff
(98.4 %id)
BF664535 B-cells, primary B-cells from tonsils (cell line) .d 1 to 803 29 to 823       797/953
(83 %)
33 diff
(96.6 %id)
BQ056701 lymph, lymphoma, cell line .d 18 to 807 1 to 794   tiling clone,   794/1033
(76 %)
22 diff
(97.9 %id)
BG341616 B-cells, primary B-cells from tonsils (cell line) .d 21 to 803 1 to 780       782/936
(83 %)
15 diff
(98.4 %id)
BM928246 brain .d 22 to 823 1 to 808   tiling clone,   808/1122
(72 %)
24 diff
(97.9 %id)
BM477913 lymph, lymphoma, cell line .d 79 to 805 1 to 730       730/1034
(70 %)
12 diff
(98.9 %id)
BM452223 melanotic melanoma, skin .d 88 to 831 12 to 753   tiling clone,   742/1129
(65 %)
16 diff
(98.6 %id)
BM557856 astrocytoma grade IV, cell line, brain .d 96 to 813 1 to 723   tiling clone,   723/1014
(71 %)
16 diff
(98.5 %id)
CR976715 T-Lymphocytes .d 148 to 809 1 to 661   tiling clone,   661/666
(99 %)
5 diff
(99.3 %id)
BE883434 leiomyosarcoma, uterus .d 180 to 767 1 to 588       588/588
(100 %)
0 diff
(100 %id)
AW248101 lung, small cell carcinoma .d 299 to 757 9 to 467       459/467
(98 %)
6 diff
(98.8 %id)
BM821281 stomach .d 457 to 802 1 to 346       346/346
(100 %)
0 diff
(100 %id)
BE712028 head_neck .d 483 to 807 341 to 17   tiling clone,   325/341
(95 %)
0 diff
(100 %id)
CR620810 Neuroblastoma Cot 25-normalized .e 1 to 1461 1 to 1461 exact tiling clone,   1461/1461
(100 %)
0 diff
(100 %id)
BG340017 leiomyosarcoma cell line, uterus .e 213 to 920 1 to 704       704/721
(97 %)
35 diff
(95.2 %id)
CR617493 T cells (Jurkat cell line) Cot10-normalized .f 1 to 1574 1 to 1574 exact tiling clone,   1574/1574
(100 %)
0 diff
(100 %id)
BE896336 melanotic melanoma, skin .g 1 to 707 1 to 712 F75S K76N C77V E78R K79N ... tiling clone,   712/957
(74 %)
59 diff
(93.9 %id)
BI089859 cervix .g 64 to 970 1 to 908   tiling clone,   908/908
(100 %)
56 diff
(93.9 %id)
BE791874 lung, small cell carcinoma .g 376 to 408 1 to 33       756/994
(76 %)
56 diff
(94.4 %id)
BI917905 brain .h 1 to 599 1 to 598 S173P C174V V175S C177A M178C ... tiling clone, AAA   598/598
(100 %)
2 diff
(99.7 %id)
TI_57242499   .h 1 to 599 74 to 671 S173P C174V V175S C177A M178C ... tiling clone, AAA   598/671
(89 %)
8 diff
(98.9 %id)
BF834714 head_neck .h 381 to 558 178 to 1   tiling clone, Submitted on the opposite strand 178/180
(98 %)
10 diff
(94.5 %id)
CR592729 Neuroblastoma Cot 25-normalized .i 1 to 1257 1 to 1257 exact tiling clone,   1257/1257
(100 %)
0 diff
(100 %id)
BI481129 Native Retinal Pigment Epithelium sheets, retina .j 1 to 479 12 to 491   tiling clone,   480/496
(96 %)
13 diff
(97.4 %id)
TI_154004475   .j 346 to 849 631 to 128   tiling clone,   504/682
(73 %)
16 diff
(97.7 %id)
CA433666 mixed .j 465 to 845 398 to 19   tiling clone, AAA   380/390
(97 %)
6 diff
(98.5 %id)
CR981400 T-Lymphocytes .k 1 to 933 1 to 934 exact tiling clone,   934/938
(99 %)
8 diff
(99.2 %id)
AW498929 brain .k 58 to 399 1 to 342       342/342
(100 %)
0 diff
(100 %id)
T09084   .k 58 to 443 1 to 390       390/390
(100 %)
4 diff
(99.0 %id)
BU902165 leiomyosarcoma, uterus .k 153 to 1176 1 to 1029   tiling clone,   1029/1181
(87 %)
35 diff
(97.1 %id)
BU508720 leiomyosarcoma, uterus .k 153 to 1047 1 to 903       903/926
(97 %)
36 diff
(96.2 %id)
BG334071 melanotic melanoma, skin .k 158 to 861 1 to 699       699/704
(99 %)
26 diff
(96.4 %id)
BG476352 melanotic melanoma, skin .k 158 to 772 1 to 621       621/745
(83 %)
21 diff
(97.2 %id)
BG478548 melanotic melanoma, skin .k 158 to 884 1 to 736       736/737
(99 %)
16 diff
(97.9 %id)
BE727647 melanotic melanoma, skin .k 178 to 990 1 to 806       806/994
(81 %)
45 diff
(95.5 %id)
BE728734 melanotic melanoma, skin .k 178 to 920 1 to 734       734/745
(98 %)
16 diff
(97.9 %id)
CX787468 human embryonic stem cells .k 191 to 922 1 to 732   tiling clone,   732/734
(99 %)
2 diff
(99.8 %id)
BG770774 melanotic melanoma, high MDR (cell line), skin .k 205 to 770 59 to 634       576/634
(90 %)
31 diff
(95.2 %id)
TI_59394160   .k 205 to 988 91 to 873       783/833
(93 %)
15 diff
(98.2 %id)
BM016538 breast, mammary adenocarcinoma, cell line .k 206 to 988 1 to 782   tiling clone,   782/832
(93 %)
15 diff
(98.2 %id)
BQ231882 embryonal carcinoma, cell line, testis .k 206 to 1047 1 to 843   tiling clone,   843/877
(96 %)
24 diff
(97.3 %id)
BG828643 muscle, rhabdomyosarcoma .k 211 to 892 1 to 669       669/771
(86 %)
49 diff
(93.7 %id)
CR985509 T-Lymphocytes .k 211 to 873 1 to 664       664/668
(99 %)
4 diff
(99.5 %id)
CT003131 T-Lymphocytes .k 211 to 929 1 to 724       724/729
(99 %)
11 diff
(98.5 %id)
BF803354 colon_ins .k 214 to 664 461 to 13     Submitted on the opposite strand 449/461
(97 %)
1 diff
(99.8 %id)
BU159445 eye, retinoblastoma .k 219 to 1047 1 to 843   tiling clone,   843/876
(96 %)
29 diff
(96.7 %id)
BE378094 endometrium, adenocarcinoma cell line, uterus .k 237 to 918 1 to 676       676/727
(92 %)
14 diff
(98.1 %id)
BG489979 large cell carcinoma, lung .k 237 to 852 1 to 625       625/765
(81 %)
31 diff
(96.0 %id)
BE393694 endometrium, adenocarcinoma cell line, uterus .k 238 to 774 1 to 539       539/539
(100 %)
4 diff
(99.3 %id)
BE562998 endometrium, adenocarcinoma cell line, uterus .k 240 to 997 1 to 755       755/881
(85 %)
24 diff
(97.3 %id)
BF346448 anaplastic oligodendroglioma with 1p/19qloss, brain .l 1 to 646 1 to 644 P12R L13* tiling clone,   644/644
(100 %)
5 diff
(99.3 %id)
DA877382 Prostate .m 1 to 583 2 to 584   tiling clone, capped   583/583
(100 %)
0 diff
(100 %id)
BE729948 melanotic melanoma, skin .m 46 to 839 1 to 776 G17V P18L H19T H20M V21S ...     776/781
(99 %)
42 diff
(94.7 %id)
BP326307 prostata .m 65 to 583 1 to 520       520/528
(98 %)
5 diff
(99.1 %id)
BP377371 uterus .m 65 to 637 1 to 574 S15X Q16P P18S H19S H20P ...     574/574
(100 %)
8 diff
(98.7 %id)
BI772720 pooled lung and spleen .m 71 to 654 28 to 616 K12N V13G H14A S15Q Q16P ...     589/779
(75 %)
18 diff
(97.7 %id)
TI_57178123   .m 71 to 654 28 to 616 K12N V13G H14A S15Q Q16P ...     589/779
(75 %)
18 diff
(97.7 %id)
BP299351   .m 87 to 642 1 to 565 H75I L76W A79G P81A V83P ...     565/565
(100 %)
14 diff
(97.6 %id)
BM548174 brain, hippocampus .m 100 to 599 7 to 503       497/1326
(37 %)
13 diff
(99.1 %id)
BM548269 brain, hippocampus .m 100 to 555 1 to 455       455/1490
(30 %)
12 diff
(99.2 %id)
TI_57189642   .m 103 to 798 25 to 711 G17V P18L H19T H20M V21S ...     687/688
(99 %)
25 diff
(96.4 %id)
BI860262 breast, mammary adenocarcinoma, cell line .m 104 to 798 1 to 686 G17V P18L H19T H20M V21S ...     686/687
(99 %)
25 diff
(96.4 %id)
AL527849 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .m 109 to 745 1 to 623 D86X fully sequenced,   623/623
(100 %)
18 diff
(97.2 %id)
BI838850 pooled pancreas and spleen .m 111 to 831 26 to 753 P82L V83S P84G G85R D86R ...     728/840
(86 %)
27 diff
(96.8 %id)
TI_57162323   .m 111 to 831 26 to 753 P82L V83S P84G G85R D86R ...     728/840
(86 %)
27 diff
(96.8 %id)
BE905093 epithelioid carcinoma, Pancreas .m 116 to 644 1 to 540 D9E H10P M11H K12D V13R ...     540/938
(57 %)
37 diff
(96.1 %id)
BG831008 epithelioid carcinoma cell line, Pancreas .m 116 to 778 1 to 662 G17V P18L H19T H20M V21S ... tiling clone,   662/662
(100 %)
7 diff
(99.0 %id)
AW960298   .m 117 to 599 1 to 482       482/657
(73 %)
5 diff
(99.3 %id)
BX374558 Neuroblastoma Cot 10-normalized .m 119 to 926 1 to 807 exact tiling clone, fully sequenced,   807/807
(100 %)
1 diff
(99.9 %id)
TI_57182658   .m 122 to 601 19 to 503       485/948
(51 %)
12 diff
(98.8 %id)
BX332552 Neuroblastoma Cot 25-normalized .m 125 to 1089 9 to 970 exact tiling clone,   962/970
(99 %)
12 diff
(98.8 %id)
BI771216 pooled lung and spleen .m 133 to 601 1 to 474       474/919
(51 %)
7 diff
(99.3 %id)
BE910709 epithelioid carcinoma, Pancreas .m 149 to 815 10 to 676 P81R P82L V83S P84R G85E ...     667/806
(82 %)
32 diff
(96.1 %id)
BI917193 brain .m 189 to 844 1 to 657 A80G P92H T93H C94L     657/657
(100 %)
9 diff
(98.7 %id)
AL527848 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .m 715 to 1707 985 to 1   tiling clone, fully sequenced,   985/985
(100 %)
18 diff
(98.2 %id)
BX374557 Neuroblastoma Cot 10-normalized .m 896 to 1660 807 to 46   tiling clone, fully sequenced,   762/807
(94 %)
68 diff
(91.6 %id)
CR607928 Neuroblastoma Cot 25-normalized .n 1 to 1595 1 to 1595 exact tiling clone,   1595/1595
(100 %)
0 diff
(100 %id)
CR612001 Neuroblastoma Cot 25-normalized .n 429 to 1619 1 to 1191   tiling clone,   1191/1191
(100 %)
0 diff
(100 %id)
BQ940786 leiomyosarcoma, uterus .o 1 to 604 1 to 609 A48G A49S V50S A51N A52S ... tiling clone,   609/975
(62 %)
18 diff
(98.2 %id)
BP223959 colon mucosa .o 46 to 385 1 to 340       340/344
(98 %)
2 diff
(99.5 %id)
CB594368 Blood, promyelocytic leukemia .o 55 to 834 1 to 789 A42G A43G A44S A45G A46S ...     789/885
(89 %)
20 diff
(97.8 %id)
BM560966 amelanotic melanoma, cell line, skin .o 57 to 738 1 to 687 exact     687/1034
(66 %)
15 diff
(98.6 %id)
BM808305 amelanotic melanoma, cell line, skin .o 58 to 928 1 to 883 exact     883/1057
(83 %)
33 diff
(96.9 %id)
AI815427 brain, frontal lobe .o 59 to 527 1 to 469       469/469
(100 %)
0 diff
(100 %id)
AI929724 brain, frontal lobe .o 59 to 519 1 to 461       461/468
(98 %)
1 diff
(99.8 %id)
AW160502 brain, frontal lobe .o 59 to 519 1 to 461       461/468
(98 %)
1 diff
(99.8 %id)
CN258669 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .o 60 to 767 8 to 715 exact     708/715
(99 %)
7 diff
(99.1 %id)
AA329229   .o 63 to 298 1 to 236       236/240
(98 %)
4 diff
(98.4 %id)
CR621035 T cells (Jurkat cell line) Cot10-normalized .o 65 to 1466 1 to 1402 exact     1402/1402
(100 %)
0 diff
(100 %id)
TI_57216773   .o 65 to 995 32 to 962 exact     931/1086
(85 %)
38 diff
(96.6 %id)
BI756681 brain .o 66 to 995 1 to 930 exact     930/1054
(88 %)
33 diff
(96.9 %id)
CN258674 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .o 74 to 656 13 to 597 V66G P67A V68C S69E S70L ...     585/597
(97 %)
11 diff
(98.2 %id)
BI769798 pooled lung and spleen .o 74 to 866 1 to 794 exact     794/795
(99 %)
14 diff
(98.3 %id)
BM545963 ovary (pool of 3) .o 74 to 813 10 to 751 exact     742/1174
(63 %)
18 diff
(98.5 %id)
BQ951550 leiomyosarcoma, uterus .o 74 to 942 1 to 888 exact     888/956
(92 %)
35 diff
(96.4 %id)
TI_57179497   .o 74 to 866 70 to 863 exact     794/864
(91 %)
19 diff
(97.9 %id)
AA351418 brain .o 75 to 450 1 to 376       376/376
(100 %)
2 diff
(99.5 %id)
BM006582 ductal carcinoma, cell line, Pancreas .o 75 to 696 1 to 635 V50S A51S A52S P54S T55H ...     635/697
(91 %)
19 diff
(97.3 %id)
BQ233167 epithelioid carcinoma, Pancreas .o 75 to 835 1 to 768 exact     768/939
(81 %)
19 diff
(98.0 %id)
CN258662 embryonic stem cells, cell lines H1, H7, andH9 .o 76 to 606 12 to 542 exact     531/542
(97 %)
6 diff
(98.9 %id)
TI_59395692   .o 76 to 696 59 to 692 V50S A51S A52S P54S T55H ...     634/696
(91 %)
18 diff
(97.5 %id)
TI_57218044   .o 77 to 922 27 to 874 exact     848/875
(96 %)
17 diff
(98.1 %id)
BI753413 brain .o 82 to 922 1 to 843 exact     843/844
(99 %)
12 diff
(98.6 %id)
DB502103.
matches multiple genes
hypothalamus .o 85 to 562 1 to 478     also hits gene LOC100289283 478/478
(100 %)
2 diff
(99.6 %id)
TI_57216108   .o 87 to 968 65 to 956 exact     892/969
(92 %)
27 diff
(97.3 %id)
CR604629 Placenta Cot 25-normalized .o 96 to 1466 1 to 1371 exact     1371/1371
(100 %)
0 diff
(100 %id)
BX379836 Placenta Cot 25-normalized .o 96 to 811 1 to 726 V50A P53V P54A T55A A56P ... fully sequenced,   726/726
(100 %)
9 diff
(98.8 %id)
BM806221 leiomyosarcoma, uterus .o 98 to 785 1 to 696 exact     696/1080
(64 %)
14 diff
(98.8 %id)
BM042193 melanotic melanoma, cell line, skin .o 98 to 701 1 to 611 A45G A46S A47S A48W A49Q ...     611/618
(98 %)
11 diff
(98.3 %id)
BU177970 melanotic melanoma, cell line, skin .o 100 to 720 1 to 629 exact     629/968
(64 %)
17 diff
(98.3 %id)
BU166742 melanotic melanoma, cell line, skin .o 100 to 836 1 to 748 exact     748/973
(76 %)
18 diff
(98.2 %id)
BI754969 brain .o 102 to 968 1 to 878 exact     878/891
(98 %)
21 diff
(97.7 %id)
AA356980   .o 103 to 419 1 to 319       319/323
(98 %)
5 diff
(98.5 %id)
TI_57217999   .o 103 to 813 32 to 741 G17V P18L H19T H20M V21S ...     710/741
(95 %)
9 diff
(98.8 %id)
BI753237 brain .o 104 to 813 1 to 709 G17V P18L H19T H20M V21S ...     709/709
(100 %)
4 diff
(99.5 %id)
BG034340 breast, mammary adenocarcinoma, cell line .o 106 to 867 1 to 767 exact     767/1176
(65 %)
36 diff
(97.0 %id)
BF205963 brain, neuroblastoma .o 110 to 750 1 to 640 exact     640/640
(100 %)
1 diff
(99.9 %id)
BG254109 adenocarcinoma, cell line, Prostate .o 120 to 731 1 to 615 exact     615/968
(63 %)
11 diff
(98.9 %id)
BI116946 lung, small cell carcinoma .o 127 to 682 1 to 556 exact     556/657
(84 %)
11 diff
(98.4 %id)
BF527504 anaplastic oligodendroglioma with 1p/19qloss, brain .o 128 to 740 1 to 618 C33S P77T AAA   618/842
(73 %)
24 diff
(97.2 %id)
CR991615 T-Lymphocytes .o 130 to 808 1 to 679 exact     679/680
(99 %)
3 diff
(99.6 %id)
CR624746 thymus .o 167 to 1505 1 to 1339 exact tiling clone,   1339/1339
(100 %)
0 diff
(100 %id)
BX379835 Placenta Cot 25-normalized .o 781 to 1466 684 to 1   fully sequenced,   684/684
(100 %)
5 diff
(99.3 %id)
AI816365 brain, frontal lobe .o 1023 to 1505 502 to 20   AAA   483/483
(100 %)
4 diff
(99.2 %id)
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI